Replies to post #276867 on Avid Bioservices Inc (CDMO)

[geocappy1]

I am in on any LS that goes after the legitimacy of the BOD. They have had enough time and What ES has done in past was paid back by now and he should not be controlling the path of pphm any longer with his crony BOD.

I said voting no on the last two votes would have brought them back to us needing to make concessions. Unfortunately, there are too many shares out there friendly to this group..

IMO a LS for removal of the crony BOD is the only option left. They have had enough time.

[wwtmm]

Nice post Jake...........I'm still doubtful that they have given up on go it alone. It's hard to believe that some sort of a money deal can't be inked. No sense of urgency it's as if the people on the board are immune from getting older.

[goodJohnhunting]

to me the issue or focus should be how to make b2gp1 more effective so as to expand the range

That's 1 of 3 (two ton elephants) in the room, and forget b2gp1 as a reliable marker for Bavituximab, as we know it, imo.

1)Binding
2)Endogenous Cross Reactivity
3)Management (The loss of Dr. Thorpe (RIP) has come to roost). If ever we needed him, it is now.

Just a note on cross reactivity. It's my opinion that Bavituximab is the least-common denominator in competition for b2gp1, insomuch that it's not interfering with normal endogenous functions, thus the lack of systemic immune AE's, IMO..

All the best,
John